BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 29546817)

  • 1. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of cobalt ferrite nanoparticles in biomedical nanotechnology.
    Srinivasan SY; Paknikar KM; Bodas D; Gajbhiye V
    Nanomedicine (Lond); 2018 May; 13(10):1221-1238. PubMed ID: 29882719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
    Mosayebi J; Kiyasatfar M; Laurent S
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
    Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
    Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices.
    Hajba L; Guttman A
    Biotechnol Adv; 2016; 34(4):354-361. PubMed ID: 26853617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T
    Shen Z; Chen T; Ma X; Ren W; Zhou Z; Zhu G; Zhang A; Liu Y; Song J; Li Z; Ruan H; Fan W; Lin L; Munasinghe J; Chen X; Wu A
    ACS Nano; 2017 Nov; 11(11):10992-11004. PubMed ID: 29039917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-Iron Oxide Nanoparticles Conjugates: Functional Magnetic Nanoplatforms in Biomedical Applications.
    Sosa-Acosta JR; Iriarte-Mesa C; Ortega GA; Díaz-García AM
    Top Curr Chem (Cham); 2020 Jan; 378(1):13. PubMed ID: 31925680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.
    Vallabani NVS; Singh S; Karakoti AS
    Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications.
    Amiri M; Salavati-Niasari M; Akbari A
    Adv Colloid Interface Sci; 2019 Mar; 265():29-44. PubMed ID: 30711796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
    Hu Y; Mignani S; Majoral JP; Shen M; Shi X
    Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
    Kumar P; Agnihotri S; Roy I
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.
    El-Sherbiny IM; Elbaz NM; Sedki M; Elgammal A; Yacoub MH
    Nanomedicine (Lond); 2017 Feb; 12(4):387-402. PubMed ID: 28078950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic nanoparticles for cancer theranostics: Advances and prospects.
    Li X; Li W; Wang M; Liao Z
    J Control Release; 2021 Jul; 335():437-448. PubMed ID: 34081996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer.
    Li Y; Xin J; Sun Y; Han T; Zhang H; An F
    Cancer Biol Med; 2020 May; 17(2):307-327. PubMed ID: 32587771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic nanoparticles based cancer therapy: current status and applications.
    Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
    Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.